NQO1 and liver cancer: Xue Lijun et al. suggested that Tyr induces the expression of phase II detoxifying enzyme NAD(P)H/quinone oxidoreductase-1 (NQO1) in liver cancer cells via the antioxidant response element (ARE), thereby inhibiting the proliferation of human liver cancer SMMC-7721 cells [181,182].